Replies to post #33743 on Relief Therapeutics Holding AG (RLFTF)

[JTORENCE]

mc67 Wrong starting this month.

Fast Track designation is well-timed as we anticipate starting our Phase 2 clinical trial in hospitalized COVID-19 patients this month, and should help bring Brilacidin to patients faster in these dire times.”